Pitcairn’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,045
| Closed | -$290K | – | 665 |
|
|
2023
Q2 | $290K | Sell |
7,045
-48
| -0.7% | -$1.97K | 0.02% | 520 |
|
|
2023
Q1 | $407K | Sell |
7,093
-123
| -2% | -$7.06K | 0.04% | 402 |
|
|
2022
Q4 | $405K | Sell |
7,216
-521
| -7% | -$29.2K | 0.04% | 366 |
|
|
2022
Q3 | $328K | Sell |
7,737
-175
| -2% | -$7.42K | 0.04% | 391 |
|
|
2022
Q2 | $427K | Sell |
7,912
-795
| -9% | -$42.9K | 0.05% | 341 |
|
|
2022
Q1 | $560K | Sell |
8,707
-739
| -8% | -$47.5K | 0.05% | 323 |
|
|
2021
Q4 | $633K | Sell |
9,446
-181
| -2% | -$12.1K | 0.04% | 310 |
|
|
2021
Q3 | $660K | Buy |
9,627
+381
| +4% | +$26.1K | 0.05% | 274 |
|
|
2021
Q2 | $631K | Sell |
9,246
-270
| -3% | -$18.4K | 0.04% | 277 |
|
|
2021
Q1 | $657K | Buy |
9,516
+198
| +2% | +$13.7K | 0.05% | 261 |
|
|
2020
Q4 | $605K | Buy |
9,318
+233
| +3% | +$15.1K | 0.05% | 254 |
|
|
2020
Q3 | $429K | Sell |
9,085
-264
| -3% | -$12.5K | 0.04% | 275 |
|
|
2020
Q2 | $439K | Buy |
9,349
+850
| +10% | +$39.9K | 0.04% | 248 |
|
|
2020
Q1 | $380K | Buy |
8,499
+1,730
| +26% | +$77.4K | 0.05% | 247 |
|
|
2019
Q4 | $394K | Buy |
6,769
+193
| +3% | +$11.2K | 0.04% | 307 |
|
|
2019
Q3 | $395K | Buy |
6,576
+175
| +3% | +$10.5K | 0.04% | 294 |
|
|
2019
Q2 | $358K | Sell |
6,401
-754
| -11% | -$42.2K | 0.04% | 326 |
|
|
2019
Q1 | $399K | Buy |
7,155
+2,009
| +39% | +$112K | 0.04% | 266 |
|
|
2018
Q4 | $232K | Sell |
5,146
-652
| -11% | -$29.4K | 0.03% | 375 |
|
|
2018
Q3 | $382K | Sell |
5,798
-362
| -6% | -$23.9K | 0.04% | 323 |
|
|
2018
Q2 | $396K | Buy |
6,160
+61
| +1% | +$3.92K | 0.04% | 303 |
|
|
2018
Q1 | $338K | Buy |
+6,099
| New | +$338K | 0.04% | 344 |
|
|
2017
Q3 | – | Sell |
-3,783
| Closed | -$207K | – | 497 |
|
|
2017
Q2 | $207K | Buy |
+3,783
| New | +$207K | 0.02% | 440 |
|